Literature DB >> 31012911

Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation.

Robert M Califf1,2, Andrew Slavitt3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31012911     DOI： 10.1001/jama.2019.3846

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.

Authors:  Eric D Shah; Jessica K Salwen-Deremer; Peter R Gibson; Jane G Muir; Shanti Eswaran; William D Chey
Journal:  MDM Policy Pract       Date:  2021-01-18

2.  Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.

Authors:  Taoyu Lin; Zhaohui Wu; Menming Liu; Xiangwei Wu; Xinping Zhang
Journal:  Int J Equity Health       Date:  2020-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.